具有侵袭性病程的雄激素相关性肝细胞癌。

Androgen associated hepatocellular carcinoma with an aggressive course.

作者信息

Gleeson D, Newbould M J, Taylor P, McMahon R F, Leahy B C, Warnes T W

机构信息

Department of Gastroenterology, Royal Infirmary, Manchester.

出版信息

Gut. 1991 Sep;32(9):1084-6. doi: 10.1136/gut.32.9.1084.

DOI:10.1136/gut.32.9.1084

PMID:1655591

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1379057/

Abstract

The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.

摘要

接受雄激素治疗的患者所发生的肝细胞癌此前一直被认为临床预后良好。我们描述了一名男性，他在接受雄激素治疗24年后发生了肝细胞癌，其肿瘤在停用雄激素后最初出现部分消退，但随后病情进展迅速并导致死亡。